Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

NCT07389408 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.

NCT NCT07389408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07389408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing
Lead sponsor
National and Kapodistrian University of Athens
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2025
Completion date
December 31, 2038
Enrollment
2,000 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast adenocarcinoma, breast cancer